The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel

Preventive Medicine

Volumn 45, Issue 5, 2007, Pages 386-391

  Chodick, Gabriel ^a,b   Green, Manfred S ^b,c   Heymann, Anthony D ^a   Rosenmann, Lena ^a,b   Shalev, Varda ^a  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

Author keywords

Epidemiology; Hepatitis A; Immunization

Indexed keywords

HEPATITIS A VACCINE; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEPATITIS A; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MORBIDITY; PHYSICIAN; PRIORITY JOURNAL; SEROLOGY; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; HEALTH POLICY; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; ISRAEL; MASS IMMUNIZATION; MIDDLE AGED;

EID: 35648941682     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2007.05.011     Document Type: Article

References (35)

1. Averhoff F., Shapiro C.N., Bell B.P., et al. Control of hepatitis A through routine vaccination of children. JAMA 286 (2001) 2968-2973
2. Bialek S.R., Thoroughman D.A., Hu D., et al. Hepatitis A incidence and hepatitis a vaccination among American Indians and Alaska Natives, 1990-2001. Am. J. Public Health 94 (2004) 996-1001
3. Castrodale L., Fiore A., and Schmidt T. Detection of immunoglobulin M antibody to hepatitis A virus in Alaska residents without other evidence of hepatitis. Clin. Infect. Dis. 41 (2005) 86-88
4. Centers for Disease Control, 1987, Community-wide outbreaks of hepatitis A, Atlanta, G.A., Hepatitis surveillance report no. 51.
5. Centers for Disease Control, 1996, Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45, 1-30
6. Chodick G., Lerman Y., Peled T., Aloni H., and Ashkenazi S. Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel. Pharmacoeconomics 19 (2001) 281-291
7. Chodick G., Lerman Y., Wood F., Aloni H., Peled T., and Ashkenazi S. Cost-utility analysis of hepatitis A prevention among health-care workers in Israel. J. Occup. Environ. Med. 44 (2002) 109-115
8. Chodick G., Ashkenazi S., and Lerman Y. The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies. J. Hosp. Infect. 62 (2006) 414-420
9. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., and Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294 (2005) 202-210
10. Gdalevich M., Grotto I.M.Y., Mimouni D., Shemer J.S., and Ashkenazi I. Hepatitis A antibody prevalence among young adults in Israel-The decline continues. Epidemiol. Infect. 121 (1998) 477-479
11. Green M., Block C., and Slater P. Rise in the incidence of viral hepatitis in Israel despite improved socioeconomic conditions. Rev. Infect. Dis. 11 (1989) 464-469
12. Hadler S. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger F., Lemon S., and Margolis H. (Eds). Viral Hepatitis and Liver Diseases (1991), Willimans and Willkins, Baltimore 14-20
13. Hanna J.N., Hills S.L., and Humphreys J.L. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland. Med. J. Aust. 181 (2004) 482-485
14. Innis B.L., Snitbhan R., Kunasol P., et al. Protection against hepatitis A by an inactivated vaccine. JAMA 271 (1994) 1328-1334
15. Israel Central Bureau of Statistics. Statistical Abstract of Israel (2005), Central Bureau of Statistics, Jerusalem
16. Jacobs R., Greenberg D., Koff R., Saab S., and Meyerhoff A. Regional variation in the cost effectiveness of childhood hepatitis A immunization. Pediatr. Infect. Dis. J. 22 (2003) 904-914
17. Jacobsen K., and Koopman J. Declining hepatitis A seroprevalence: a global review and analysis'. Epidemiol. Infect. 132 (2004) 1005-1022
18. Kligler I., Btesh D., and Koch W. Observations on two epidemics of infective hepatitis in Palestine among recent immigrants. J. Infect. Dis. 74 (1944) 234-246
19. Lee W., McKiernan P., and Kelly D. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom. J. Pediatr. Gastroenterol. Nutr. 40 (2005) 575-581
20. Lerman Y., Chodik G., Aloni H., and Ashkenazi S. How valid is the official data from the Health Department on reported morbidity in Israel? Hepatitis A as an example. Hebrew Harefuah 136 (1999) 441-445
21. Lopalco P., Salleras L., Barbouti S., et al. Hepatitis A and B in children and adolescents-What can we learn from Puglia (Italy) and Catalonia (Spain)?. Vaccine 19 (2000) 470-474
22. McMahon B.J., Beller M., Williams J., Schloss M., Tanttila H., and Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch. Pediatr. Adolesc. Med. 150 (1996) 733-739
23. Ramonet M., Ciocca M., NunÄez M., Afazani A., Arusa O., and Planes N. Etiology of viral hepatitis A in pediatric population. Spanish Medicina (B Aires) 45 (1985) 273-278
24. Reisler D., Brachot D., and Mosley J. Viral hepatitis in Israel: morbidity and mortality data. Am. J. Epidemiol. 92 (1970) 62-72
25. Samandari T., Bell B., and Armstrong G. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 22 (2004) 4342-4350
26. Schwartz E., and Raveh D. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination. Int. J. Epidemiol. 27 (1998) 118-120
27. Shah U., Habib Z., and Kleinman R. Liver failure attributable to hepatitis A virus infection in a developing country. Pediatrics 105 (2000) 436-438
28. Smith P.F., Grabau J.C., Werzberger A., et al. The role of young children in a community-wide outbreak of hepatitis A. Epidemiol. Infect. 118 (1997) 243-252
29. Sonder G., Bovee L., Baayen T., Coutinho R., and van den Hoek J. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Vaccine 24 (2006) 4962-4968
30. Staes C.J., Schlenker T.L., Risk I., et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 106 (2000) E54
31. Venczel L.V., Desai M.M., Vertz P.D., et al. The role of child care in a community-wide outbreak of hepatitis A. Pediatrics 108 (2001) E78
32. Wasley A., Samandari T., and Bell B.P. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 294 (2005) 194-201
33. Welty T.K., Darling K., Dye S., et al. Guidelines for prevention and control of hepatitis A in American Indian and Alaska Native communities. S. D. J. Med. 49 (1996) 317-322
34. Werzberger A., Mensch B., Kuter B., et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327 (1992) 453-457
35. Zhou F., Shefer A., Weinbaum C., McCauley M., and Kong Y. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004. Vaccine 25 (2007) 3581-3587